InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,625.80
(
0.16%
)
US TECH 100
19,008.40
(
-0.03%
)
Dow Jones
41,250.50
(
0.02%
)
Brent Oil
79.08
(
0.11%
)
Bitcoin
59,106.97
(
-0.65%
)
Post# of 29567
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 837
Posts 120337
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 23933

Tuesday, 06/01/2021 9:32:13 AM

Tuesday, June 01, 2021 9:32:13 AM

Post# of 29567
ABT—(-6%)—cuts_2021_non-GAAP_EPS_guidance_due to_slowdown_for_COVID_diagnostics:

https://finance.yahoo.com/news/abbott-issues-updated-2021-outlook-120000024.html

Abbott today announced an update to its financial outlook for the full-year 2021. The updated guidance is due to significantly lower recent and projected COVID-19 diagnostic testing demand. This has been driven by several factors, including significant reductions in cases in the U.S. and other major developed countries, accelerated rollout of COVID-19 vaccines globally and, most recently, U.S. health authority guidance on testing for fully vaccinated individuals.

The new guidance for 2021 non-GAAP EPS guidance is $4.30-4.50, down from the $5.00+ guidance given in April (#msg-163300631).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up